Filing Flows › Neuroone Medical Technologies (NMTC) › Recalls, complaints & regulation
Neuroone Medical Technologies (NMTC): clinical trials
Neuroone Medical Technologies (NMTC) beyond its filings: 1 active clinical trial.
Neuroone Medical Technologies' latest quarter
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Neuroone Medical Technologies have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.